RAND Europe and AIDS Foundation of Chicago have released a report that stresses that, in order to make an impact on new HIV infections globally, antiretroviral (ARV)-based HIV prevention strategies need to be closely tailored to local contexts and cultures.
Mapping Pathways is a community-led research project on the strategic use of ARV drugs for HIV prevention, involving RAND Europe, AIDS Foundation of Chicago and other partners in India, South Africa and the United States. The project involved more than 1,000 community respondents taking an online survey and interviews with several dozen key stakeholders, including policy experts, program implementers, health care professionals and advocates.
The report is at www.rand.org/randeurope/research/projects/aids-treatment-prevention.html.